×
Skip to content
ShareCafe

  • Home
  • Shares
  • Advice
  • Wealth
    • Wealth Home
    • Product Profiles
  • Property
  • Video
  • Contributors
  • Community
  • About us
  • Facebook
  • Twitter
  • YouTube
  • RSS
Main Menu
Di Brookman

Di Brookman

Di Brookman is a geologist & energy finance professional with over 30-years experience in equity and debt markets, corporate advisory, finance & communications. Di’s career experience spans Oil & Gas and LNG, mining, asset management & financial services. Her current interest lies in renewables and electric vehicles. During her career as an analyst she has worked for Citi, Credit Lyonnais Securities Asia (CLSA), Barclays de Zoette Wedd (BZW) and Westpac and is presently consulting to Corporate Connect.

Markets / Technology

Tesla Battery Day – World Domination…Eventually

September 25, 2020September 25, 2020 - by Di Brookman

Corporate Connect research analyst Di Brookman provides a review of Telsa’s Battery Day. Pioneered by Elon Musk the company has ambitious targets that it hopes to achieve through a combination of superior design, manufacturing, and supply chain management.

Read More
Markets / Shares / Technology

Will Tesla Signal The Death Of The Internal Combustion Engine At Battery Day?

September 17, 2020September 17, 2020 - by Di Brookman

Corporate Connect research analyst Di Brookman takes us on the EV Journey, explains why all eyes and ears are poised for Tesla Battery Day, and how truly exciting times might be ahead for the sector.

Read More

Recently Added

  • Inauguration Inflation
  • Lunch Report: Aussie market bounces back
  • Optimistic Investing Belies an Uncertain Outlook
  • The Unknown Unknowns
  • Australia…One Hour In…ASX up 67 points
  • ELD – Citi rates the stock as Buy
  • SUL – Credit Suisse rates the stock as Outperform
  • CGF – Morgans rates the stock as Hold

Subscribe to ShareCafe

The daily resource for hands-on investors. Market insights and investment ideas delivered free to your inbox.

Copyright 2020 Informed Investor Pty Ltd ABN 42 162 871 589. All rights reserved.
No portion of this website maybe reproduced, copied or in any way released without written permission.
Share Cafe is a Corporate Authorised Representative (001283561) of PacReef Asset Management Pty Ltd who holds an Australian Financial Services Licence (Number: 488045)

Terms of Service | Financial Services Guide | Privacy Policy | Contact | Advertise

DOWNLOAD RESEARCH REPORT

And a Door Opens Wide

Antisense Therapeutics’ lead drug sits at the nexus of two areas of drug development that are starting to grow dramatically in importance. One relates to its mode of action and the other to the type of drug it is. Combine that with management who know the drug very well and strong results in a trial in a horrible disease afflicting children, and you have the basis for true value creation.

SMSFBrokerFinancial AdviserRetail Investor

Please prove you are human by selecting the Star.


DOWNLOAD RESEARCH REPORT

Fit for tough times; prepared for coal’s upswing

Terracom has counter-cyclically placed itself in a position to improve efficiency and margins plus pursue organic mine growth. Cashflows will further swell once currently depressed coal prices rebound. These assets appear undervalued compared to our Base Case $0.27/share NPV valuation of TER. TER has upside on management’s record of delivering new projects from currently controlled development assets and/or by opportunistically securing acquisitions.

SMSFBrokerFinancial AdviserRetail Investor

Please prove you are human by selecting the Key.

DOWNLOAD RESEARCH REPORT

A Laser-Like Focus on Adding Value

Since August 1st, Kazia Therapeutics has announced US Food & Drug Administration fast track status for one program & orphan drug and rare paediatric disease designation for another, while finishing the period by announcing a new trial for its cancer drug, paxalisib. Over the next nine months investors are likely to see six data readouts from five programs. How fast can a company go?

SMSFBrokerFinancial AdviserRetail Investor

Please prove you are human by selecting the Heart.